Postsurgical Adjuvant Tumor Therapy by Combining Anti-Angiopoietin-2 and Metronomic Chemotherapy Limits Metastatic Growth

Cancer Cell - United States
doi 10.1016/j.ccell.2014.11.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Metronomic Chemotherapy in Metastatic Breast Cancer

Novel Research in Sciences
2019English

Anti-Vegfr2 Therapy Delays Growth of Preclinical Pediatric Tumor Models and Enhances Anti-Tumor Activity of Chemotherapy

Oncotarget
Oncology
2019English

Radiotherapy-Assisted Tumor Selective Metronomic Oral Chemotherapy

International Journal of Cancer
Cancer ResearchOncology
2017English

Methylseleninic Acid Restricts Tumor Growth in Nude Mice Model of Metastatic Breast Cancer Probably via Inhibiting Angiopoietin-2

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Anti-Tumor Innate Immunity Activated by Intermittent Metronomic Cyclophosphamide Treatment of 9L Brain Tumor Xenografts Is Preserved by Anti-Angiogenic Drugs That Spare VEGF Receptor 2

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy

Pharmaceutics
Pharmaceutical Science
2019English

Quality of Life in Patients With Metastatic Breast Cancer Treated With Metronomic Chemotherapy

Future Oncology
MedicineCancer ResearchOncology
2016English

A Study of Capecitabine Metronomic Chemotherapy Is Non-Inferior to Conventional Chemotherapy as Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer

Trials
MedicinePharmacology
2020English

Metronomic Chemotherapy Enhances the Efficacy of Antivascular Therapy in Ovarian Cancer

Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy